Who is sponsoring NCT00284388?

NCT00284388 is sponsored by University Hospital, Ghent.

What drugs are being tested in NCT00284388?

Interventions in NCT00284388: Simultaneous controlled power measurement, Surface EMG measurement.

What condition does NCT00284388 study?

NCT00284388 studies Shoulder Prosthesis.

Is NCT00284388 still recruiting?

NCT00284388 is currently withdrawn. Last updated 7 July 2021.

Last reviewed 2021-07-07 · How we verify

NCT00284388

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Incorporation of Muscle Qualities in Biomechanical Models of the Upper Limbs

Withdrawn NA Last updated 7 July 2021

What this trial tests

NA trial testing Simultaneous controlled power measurement in Shoulder Prosthesis. Withdrawn.

Quick facts

Lead sponsor	University Hospital, Ghent
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	diagnostic

Drugs / interventions tested

Simultaneous controlled power measurement
Surface EMG measurement

Conditions studied

Shoulder Prosthesis — all drugs for Shoulder Prosthesis →

Sponsor

University Hospital, Ghent

Who can join

Adults 40 to 70, any sex, with Shoulder Prosthesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Development of a non-invasive method for the determination of the position of optimal muscle length in the different muscles of the shoulder. Analysis of the adaptation of the muscle to a new optimal length in patients with a shoulder prosthesis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Shoulder Prosthesis

Currently open trials in the same condition.

NCT04431973 — Open-label, Prospective, Multicenter, Post-market Study to Evaluate the Reverse Medacta Shoulder System of Total Shoulde · NA · active not recruiting

Other University Hospital, Ghent trials

Trials by the same sponsor.

NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00284388 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
Last refreshed: 7 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00284388.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing